查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197167

中空纤维过滤市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Hollow Fiber Filtration Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内 (2022-2027)，中空纤维过滤市场预计将以 14.1% 的复合年增长率註册。

在 COVID-19 阶段，由于人口中传染病病例的增加，预计中空纤维过滤市场将增长。 对 COVID-19 疫苗和疗法的需求不断增加正在推动中空纤维过滤市场的增长。 根据 Computational and Structural Biotechnology Journal 2021 年 5 月发表的一篇题为“当前 COVID-19 疫苗平台概述”的文章，有 184 种候选疫苗处于临床前测试阶段，88 种处于临床阶段。据说它曾是 中空纤维过滤是回收 COVID-19 候选疫苗的重要下游工艺，因为它有利于高选择性和有效的候选疫苗。 因此，预计 COVID-19 将在整个大流行期间增加对中空纤维过滤技术的需求。

生物製药行业研发投资的增加是推动市场增长的主要因素之一。 对生物製药的需求不断增长，加上质量标准不断提高以满足市场参与者的监管要求，预计将对市场增长产生积极影响。 根据美国国会预算办公室2020年发布的一份报告，生物製药行业在研发活动上的支出约为830亿美元。 此外，2021 年 7 月，世界卫生组织 (WHO) 加速器从各国政府筹集了 120 亿美元的疫苗资金，其中包括 17 亿美元的研发支持。 生物製药领域研发投入的增加有望推动中空纤维膜过滤市场的增长。

此外，由于过滤是标准单元操作中必不可少的步骤，因此全球批准的生物製药数量不断增加以及生物製药产量的增加正在推动对中空纤维过滤市场的需求。 2020 年，美国食品和药物管理局 (FDA) 平均每年批准 53 种新药。 这种研发活动的增加，加上生物製药产品批准的增加，预计将推动市场增长。

因此，由于上述因素，市场有望在预测期内出现增长。 然而，政府对药品安全的严格监管可能会阻碍市场增长。

中空纤维过滤市场趋势

在中空纤维过滤市场，製药和生物技术行业预计将占据主要市场份额。

由于在生产过程中广泛使用中空纤维过滤，预计製药和生物技术行业将成为最赚钱的行业。 製造过程中超滤、渗滤和微滤工艺对中空纤维的需求不断增长，以及製药和生物技术领域对连续製造技术的使用不断增加，预计将推动市场增长。

中空纤维过滤的使用降低了与復杂的下游工艺相关的成本，从而提高了生产率并有助于遵守良好生产规范 (GMP) 和食品药品监督管理局 (FDA) 的过滤指南。 由于中空纤维过滤在产品分离和纯化中的广泛应用，製药和生物製药行业研发活动投资的增加将直接影响对中空纤维过滤的需求。 例如，2022 年 4 月，辉凌製药在海得拉巴开设了一个综合研发和製造设施，总投资为 3000 万欧元。 研发能力包括配方开发、包装开发和分析开发。 製药行业的这种增长导致越来越多地使用中空纤维膜进行产品过滤，从而促进了该行业的增长。

因此，由于上述因素，预计製药和生物技术行业板块在预测期内将会增长。

北美将占据很大的市场份额，预计在预测期内也会如此

由于该地区生物製药领域研发活动的增加，预计美国地区的中空纤维过滤市场将会增长。 根据 Binder Dijker Otte (BDO) USA Reports，生物技术指数 (NBI) 上市公司的收入在 2020 年增长了 10.49 亿日元。 2020年，美国製药行业平均研发支出增长16%，达到2.8425亿美元。 如此一来，加上美国地区对生物类似药产品的需求增加，研发活动活跃，其在治疗药物下游工艺中的广泛应用，有利于中空纤维过滤市场的增长，我们提供了机会。 例如，2020 年 3 月，Thermo Fisher Scientific 投资约 4.75 亿美元，用于扩大其生物製剂、细胞和基因治疗以及药物开发设施，并提高其全球商业能力。 同样，2020 年 1 月，礼来公司签订了收购生物製药公司 Dermira 的协议。

此外，由于主要市场参与者的存在和产品开发的先进技术，预计该地区将占据最大份额。 此外，不断增加的研发活动和有利的医疗保健基础设施的存在极大地推动了该地区的市场增长。

中空纤维过滤市场竞争者分析

中空纤维过滤市场竞争激烈，由几家大型企业组成。 从市场份额的角度来看，一些主要参与者目前主导着市场。 目前主导市场的一些公司是 Repligen Corporation、Sartorius、Danaher Corporation、Asahi Kasei Medical、Parker Hannifin Corp、Mar cor、Koch Separation solutions、Meissner Filtration Products, Inc、Antilia Scientific 和 Biotree。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 增加对生物製药研发的投资
    • 越来越喜欢连续製造
  • 市场製约因素
    • 关于药物安全的严格政府法规
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分

  • 按材料
    • 高分子材料
    • 陶瓷
  • 按技术
    • 微滤
    • 超滤
  • 最终用户
    • 製药和生物技术行业
    • 研究所
    • 委託研究机构
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Repligen Corporation
    • Sartorius
    • Danaher Corporation
    • Asahi Kasei Medical Co., Ltd
    • Parker Hannifin Corp
    • Mar cor
    • Koch Seperation solutions
    • Meissner Filtration Products, Inc
    • Antylia Scientific
    • Biotree

第7章 市场机会今后动向

简介目录
Product Code: 90456

The Hollow Fiber Filtration Market is projected to register a CAGR of 14.1% during the forecast period (2022-2027).

Amid COVID-19 phase, the hollow fiber filtration market is expected to grow owing to the rising cases of infectious diseases among the population. An increase in the demand for vaccines and treatment drugs for COVID-19 is a driving factor for the growth of the hollow fiber filtration market. According to the article titled "An overview of current COVID-19 vaccine platforms" published by the Computational and Structural Biotechnology Journal in May 2021, there were 184 vaccine candidates in preclinical testing and another 88 vaccine candidates in clinical phases. The hollow fiber filtration method is a crucial process in the downstream process for the recovery of the COVID-19 vaccine candidates as the hollow fiber filtration favors high selectivity and effective vaccine candidates. Hence, COVID-19 is assumed to increase the demand for the hollow fiber filtration techniques throughout the pandemic phase.

The increasing investment in the research and development of the biopharmaceutical industry is one of the major factors driving the market's growth. The growing demand for biopharmaceutical drugs coupled with the continuous improvement of quality standards to meet the regulatory requirements by the market players is expected to have a positive impact on the growth of the market. The report published by the Congressional Budget Office in 2020 stated that the biopharmaceutical industry spent around 83 billion USD on research and developmental activities. Additionally, in July 2021, the World Health Organization (WHO) accelerator raised 12 billion USD in funding for the vaccines from various governments, including USD 1.7 billion for research and development support. Such an increase in the investment in the research and development of the biopharmaceutical sector is expected to boost the growth of the hollow fiber filtration market.

Furthermore, an increase in the number of approved biopharma products worldwide and increasing manufacturing of biopharmaceutical drugs is expected to increase the demand for the hollow fiber filtration market as filtration is an essential step in the standard unit operation. In 2020, the United States Food and Drug Administration (FDA) approved an average of 53 new medicines annually. Such an increase in research and developmental activities coupled with the increasing product approvals of biopharmaceuticals is expected to drive the market's growth.

Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period. However, strict government regulations related to drug safety may hinder the growth of the market.

Hollow Fiber Filtration Market Trends

The Pharmaceuticals and Biotechnology Industries Segment is Expected to Hold a Major Market Share in the Hollow Fiber Filtration Market Market.

The pharmaceutical and biotechnology industries are expected to be the most lucrative segment, with extensive usage of hollow fiber filtration in their production processes. The expanding demand for hollow fibers in ultrafiltration, diafiltration, and microfiltration processes in the manufacturing process and the increased usage of continuous manufacturing techniques in the pharma and biotech sectors is expected to propel the growth of the market.

The usage of hollow fiber filtration helps decrease the costs associated with the complicated downstream processing, thereby increasing productivity and helping in the adherence to Good Manufacturing Process (GMP) and Food and Drug Administration (FDA) guidelines for filtration. The growth in investement for research and development activities of the pharmaceutical and biopharmaceutical industries directly impacts the demand for hollow fiber filtration owing to the extensive usage for isolation and purification of the products. For instance, in April 2022, Ferring Pharmaceuticals opened its integrated R&D and manufacturing facility in Hyderabad, which was established with a total investment of EUR 30 million. The R&D capability includes formulation development, packaging development, and analytical development. This increase in the growth of the pharmaceutical sector facilitates the increasing usage of hollow fiber filtration for filtration of products, thereby propelling the growth of the segment.

Thus, owing to the abovementioned factors, the pharmaceutical and biotechnology industries segment is expected to grow over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period.

The hollow fiber filtration market is expected to grow in this region owing to the increase in research and development activities in the biopharma sector in the United States region. According to the Binder Dijker Otte (BDO) USA Reports, in 2020, companies listed on the biotechnology index (NBI) saw a growth in revenue of 1.049 billion. In 2020, average research and development spending increased by 16% to 284.25 million USD in the United States pharmaceutical industry. Thus, the increasing research and development activities, coupled with the increasing demand for biosimilar products in the United States region, provide lucrative opportunities for the growth of the hollow fiber filtration market as they are extensively used for the downstream process of therapeutics. For instance, in March 2020, Thermo Fisher Scientific Inc. invested nearly USD 475 million to expand its biologics, cell and gene therapy, and drug product development facilities and increase its global commercial capabilities. Similarly, in January 2020, Eli Lilly and Company entered an agreement to acquire Dermira, a biopharmaceutical company.

Moreover, the presence of major market players and advanced technologies for product development is expected to mark this region as the one with the most dominating share. Additionally, an increase in research and development activities and the presence of favorable healthcare infrastructure are fueling the growth of the overall regional market to a large extent.

Hollow Fiber Filtration Market Competitor Analysis

The Hollow Fiber Filtration Market is competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market are Repligen Corporation, Sartorius, Danaher Corporation, Asahi Kasei Medical Co. Ltd, Parker Hannifin Corp, Mar cor , Koch Separation solutions, Meissner Filtration Products, Inc, Antylia Scientific, and Biotree.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing investment in the Research and development of Biopharmaceuticals
    • 4.2.2 Increasing preference for continous manufacturing
  • 4.3 Market Restraints
    • 4.3.1 Strict government regulations related to drug safety
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Material
    • 5.1.1 Polymer
    • 5.1.2 Ceramic
  • 5.2 By Technique
    • 5.2.1 Microfiltration
    • 5.2.2 Ultrafiltration
  • 5.3 By End user
    • 5.3.1 Pharmaceutical and Biotechnology Industries
    • 5.3.2 Research Organizations
    • 5.3.3 Contract Research Organization
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Repligen Corporation
    • 6.1.2 Sartorius
    • 6.1.3 Danaher Corporation
    • 6.1.4 Asahi Kasei Medical Co., Ltd
    • 6.1.5 Parker Hannifin Corp
    • 6.1.6 Mar cor
    • 6.1.7 Koch Seperation solutions
    • 6.1.8 Meissner Filtration Products, Inc
    • 6.1.9 Antylia Scientific
    • 6.1.10 Biotree

7 MARKET OPPORTUNITIES AND FUTURE TRENDS